Laboratory evaluation of the efficacy of Liastene application in complex therapy of multiresistant pulmonary tuberculosis
Abstract
OBJECTIVE. Evaluating according to laboratory tests the effectiveness of Liasten in the treatment of patients with multidrug-resistant pulmonary tuberculosis (MDR-TB).
MATERIALS AND METHODS. Evaluation of the effectiveness of etiotropic and etiopathogenetic therapy in 57 patients with MDR-TB was performed. According to the treatment schemes, patients were divided into groups. The control group (n=22) received individualized antimycobacterial therapy (AMBT) regimens. The experimental group (n=35) received AMBT in combination with Liasten. Evaluation of the effectiveness of treatment regimens was performed on the basis of indicators of general clinical blood tests, immunological and bacteriological studies.
RESULTS AND DISCUSSION. In patients of the experimental group, compared with the control in 1.5 times more often found positive changes in the hemogram of blood and ESR (p<0.05-0.001), the establishment of a dynamic balance between the pools of lymphocyte cells CD4+ and СD8+ (immunoregulatory index, p<0.05), an increase in the number of phagocytosis active cells (phagocytic index, p<0.05), the content of cationic lysosomal proteins of granulocyte leukocytes (p<0.05), a 1.4-fold decrease in the cytochemical coefficient of neutrophils (p<0.05), the number of proliferated under the action of PPD-L lymphocytes (p<0.05), normalization of phagocytic counts and total redox activity of neutrophils (p<0.05), increase in frequency and reduction of anesthesia was stated.
CONCLUSIONS. Restoration of the body’s immune status, blood hemogram, increase in frequency and reduction of the time of decontamination were more active and occurred 1.5 times more often in patients receiving a complex combination of AMBT with Liasten.
References
Balasanyants G.S. Razvitiye epidemicheskogo protsessa pri tuberkuleze: vliyaniye vneshnikh i vnutrennikh faktorov. Meditsinskiy akademicheskiy zhurnal. 2014; 2: 55-59.
Vakhidova G.A., Yeremeyev V.V., Ubaydullayeva A.M. Immunologicheskiye mekhanizmy patogeneza tuberkuleza. Probl. tuberkuleza. 1991; 5:42-43.
Ilinskaya I.F. Patohenetycheskye osnovy indyvydualyzyrovannoy immunokorrektsyy pry tuberkuleze. Klinichna imunolohiya, alerholohiya, infektolohiya. 2011; 3: 55-60.
Instruktsiya dlya zastosuvannya: Liasten (Liastenum).
Kopelyan I.I., Grigoryeva M.P. Razrabotka mikromodifikatsiy kultivirovaniya kletok krovi cheloveka. Byull. eksp. biol. i med. 1972; 8: 119-122.
Lapovets L.Y., Lutsyk B.D., Lebed H.B., Akimova V.M. Posibnyk z laboratornoyi imunolohiyi: navchalnyy posibnyk dlya likariv-interniv zakladiv (fakultetiv) pislyadyplomnoyi osvity. – Lviv: Pryvatnyy pidpryyemets Soroka Taras Bohdanovych, 2008: 26-33.
Lytvynenko N.A. Faktory ryzyku shchodo vynyknennya rozshyrenoyi ta pre-rozshyrenoyi rezystentnosti MBT sered patsiyentiv z multyrezystentnym tuberkulozom. Suchasni medychni tekhnolohiyi. 2014; 2: 36-42.
Platonova I.L., Sakhelashvili M.I., Lapovets N.Y., Tkach O.A. ta in. Vplyv porushen nespetsyfichnoyi ta systemnoyi imunnoyi vidpovidi na efektyvnist khimioterapiyi multyrezystentnoho tuberkulozu lehen. Tuberkuloz, lehenevi khvoroby, VIL-infektsiya. 2019; 3 (38): 14-19.
Platonova I.L., Sakhelashvili M.I., Shtybel H.I. Alhorytm korektsiyi likuvalnykh zakhodiv u khvorykh na khimiorezystentnyy tuberkuloz lehen // Medychna nauka ta praktyka na suchasnomu istorychnomu etapi: zbirnyk materialiv mizhnarodnoyi naukovo-praktychnoyi konferentsiyi. – Kyiv: Kyivskyy medychnyy tsentr, 2018: 55-60.
Sakhelashvili M.I., Platonova I.L., Sakhelashvili-Bil O.I., Tlustova T.V. Osnovni prychyny neefektyvnosti khimioterapiyi u khvorykh na multy reystentyy tuberkuloz lehen. Infusion & Chemotherapy. 2020; 1:10-13.
Sakhelashvili M.I., Platonova I.L., Kostyk O.P. ta in. Klinichna otsinka efektyvnosti preparatu muramilpeptydnoho ryadu u khvorykh na multyrezystentnyy tuberkuloz. Ukr. pulmonol. zhurn. 2018; 2: 36-38.
Feshchenko Y.I., Melnyk V.M., Gumeniuk M.I., Lynnyk M.I. Epidemichna sytuatsiya z tuberkulozu v Ukrayini. Infusion & Chemotherapy. 2019; 4: 5-9.
Feshchenko Y.I., Lytvynenko N.A., Pohrebna M.V., Senko Y.O. ta in. Likuvannya khvorykh na multyrezystentnyy tuberkuloz ta tuberkuloz iz rozshyrenoyu rezystentnistyu mikobakteriy tuberkulozu do protytuberkuloznykh preparativ: osnovni prychyny nyzkykh rezultativ. Tuberkuloz, lehenevi khvoroby, VIL-infektsiya. 2016; 2 (25): 22-29.
Cherenko S.O. Imunopatohenez tuberkulozu. Astma ta alerhiya. 2013; 1: 32-37.
Chernushenko Y.F., Protsyuk R.G. Protivotuberkuleznyy immunitet. Ukr. pulmonol. zhurn. 2010; 46: 53-58.
Chernushenko E.F., Panasyukova A.R. Immunolohycheskye mekhanyzmy prohressyrovanyya tuberkuleza // Ekolohichni problemy u ftyziatriyi i pulmonolohiyi: materialy naukovo-praktychnoyi konferentsiyi. – Kyiv, 2004: 222-225.
This work is licensed under a Creative Commons Attribution 4.0 International License.
ISSN 
ISSN 
